UGT1A8 and posterior cortical atrophy: Considering the above results, we have taken CYP1A1, CYP2B6, CYP3A4, UGT1A8, UGT2B11, UGT2B17, UGT2B7, GAS5, XIST, SNHG6, which might be more relevant to chemotherapy or endocrine therapy resistance in PCa treatment, for subsequent study.